Bone-marrow-derived mesenchymal stem cells attenuate cognitive deficits in an endothelin-1 rat model of stroke

Restorative Neurology and Neuroscience

Volumn 33, Issue 4, 2015, Pages 579-588

  Lowrance, S A ^a,b   Fink, K D ^a,b   Crane, A ^a,b   Matyas, J ^a,b   Dey, N D ^d,e   Matchynski, J J ^a,b,f   Thibo, T ^a,b   Reinke, T ^a,b   Kippe, J ^a,b   Hoffman, C ^a,b   Sandstrom, M ^b   Rossignol, J ^a,b,c   Dunbar, G L ^a,b,d  

^a Field Neurosciences Institute Laboratory for Restorative Neurology   (United States)

^b CENTRAL MICHIGAN UNIVERSITY   (United States)

^c Children's Hospital of Michigan   (United States)

^d Field Neurosciences Institute   (United States)

^e Prevacus Inc   (United States)

^f School of Natural and Behavioral Sciences   (United States)

Author keywords

cognitive dysfunction; Endothelin 1; mesenchymal stem cells; operant conditioning; stroke

Indexed keywords

ENDOTHELIN 1;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COGNITIVE DEFECT; FEMALE; INSTRUMENTAL CONDITIONING; MALE; MEDICAL ASSESSMENT; MIDDLE CEREBRAL ARTERY; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RAT; SPATIAL OPERANT REVERSAL TASK; TASK PERFORMANCE; THROMBECTOMY DEVICE; ANIMAL; BODY WEIGHT; BRAIN; COGNITION DISORDERS; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGIC TEST; PSYCHOLOGY; SPRAGUE DAWLEY RAT; STROKE; TREATMENT OUTCOME;

ANIMALS; BODY WEIGHT; BRAIN; CHRONIC DISEASE; COGNITION DISORDERS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; FEMALE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PSYCHOLOGICAL TESTS; RATS, SPRAGUE-DAWLEY; STROKE; TREATMENT OUTCOME;

EID: 84940053062     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/RNN-130329     Document Type: Article

References (33)

1. Azizi, S.A., Stokes, D., Augelli, B.J., Di Girolamo, C. & Prockop, D.J. (1998). Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci, 95, 3908-3913.
2. Baker, W.L., Colby, J.A., Tongbram, V., Talati, R., Silverman, I.E., White, C.M., Kluger, J. & Coleman, C.I. (2011). Neurothrombectomy devices for the treatment of acute ischemic stroke: State of the evidence. Ann Intern Med, 154(4), 243-252.
3. Brekenfeld, C., Schroth, G., Mattle, H.P., Do, D.-D., Remonda, L., Mordasini, P., Arnold, M., Nedeltchev, K., Meier, N. & Gralla, J. (2009). Stent placement in acute cerebral artery occlusion: Use of a self-expandable intracranial stent for acute stroke treatment. Stroke, 40(3), 847-852.
4. Desmond, D.W., Moroney, J.T., Sano, M. & Stern, Y. (1996). Recovery of cognitive function after stroke. Stroke, 27(10), 1798-1803.
5. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D.J. & Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317.
6. Dunbar, G.L., Sandstrom, M.I., Rossignol, J. & Lescaudron, L. (2006). Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: Use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. Behav Cogn Neurosci Rev, 5(2), 63-79.
7. Fink, K.D., Rossignol, J., Crane, A.T., Davis, K.K., Bavar, A.M., Dekorver, N.W., Lowrance, S.A., Reilly, M.P., Sandstrom, M.I., von Hörsten, S., Lescaudron, L. & Dunbar, G.L. (2012). Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease. Behav Neurosci, 126(3), 479-487.
8. Genovese, R.F., Petras, J.M. & Tortella, F.C. (1992). Evaluation of transient forebrain ischemia induced by four vessel occlusion using schedule-controlled behavior. Physiol Behav, 52(5), 1025-1028.
9. Higgins, G.A., Enderlin, M., Fimbel, R., Haman, M., Grottick, A.J., Soriano, M., Richards, J.G., Kemp, J.A. & Gill, R. (2002). Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia. Eur J Neurosci, 15(11), 1827-1840.
10. Honma, T., Honmou, O., Iihoshi, S., Harada, K., Houkin, K., Hamada H. & Kocsis, J.D. (2006). Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol, 199, 56-66.
11. Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., Waxman, S.G. & Kocsis, J.D. (2011). Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain, 134(Pt 6), 1790-1807.
12. Horita, Y.O., Honmou. O., Harada, K., Houkin, K., Hamada, H. & Kocsis, J.D. (2006). Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res, 84, 1495-1504.
13. Iadecola, C. & Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat Med, 17(7), 796-808.
14. Kiprianova, I., Sandkühler, J., Schwab, S., Hoyer, S. & Spranger, M. (1999). Brain-derived neurotrophic factor improves long-term potentiation and cognitive functions after transient forebrain ischemia in the rat. Exp Neurol, 159(2), 511-519.
15. Komatsu, K., Honmou, O., Suzuki, J., Houkin, K., Hamada, H. & Kocsis, J.D. (2010). Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res, 1334, 84-92.
16. Lee, J.S., Hong, J.M., Moon, G.J., Lee, P.H., Ahn, Y.H. & Bang, O.Y. (2010). A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells, 28(6), 1099-1106.
17. Liao, W., Xie, J., Zhong, J., Liu, Y., Du, L., Zhou, B., Xu, J., Liu, P., Yang, S., Wang, J., Han, Z. & Han, Z.C. (2009). Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation, 87(3), 350-359.
18. Liu, H., Honmou, O., Harada, K., Nakamura, K., Houkin, K., Hamada, H., & Kocsis, J.D. (2006). Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain, 129, 2734-2745.
19. Liu, N., Zhang, Y., Fan, L., Yuan, M., Du, H., Cheng, R., Liu, D. & Lin, F. (2011). Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats. J Transl Med, 9, 105.
20. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PAStroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. New Engl J Med, 333(24), 1581-1587.
21. Nelson, A., Sowinski, P. & Hodges, H. (1997). Differential effects of global ischemia on delayed matching- and nonmatching-to-position tasks in thewater maze and Skinner box. Neurobiol Learn Mem, 67(3), 228-247.
22. Omori, Y., Honmou, O., Harada, K., Suzuki, J., Houkin, K. & Kocsis, J.D. (2008). Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res, 1236, 30-38.
23. Patel, M.D., Coshall, C., Rudd, A.G. & Wolfe, C.D.A. (2002). Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomes. J Am Geriatr Soc, 50(4), 700-706.
24. nd edition. San Diego, Academic Press.
25. Reeves, M.J., Arora, S., Broderick, J.P., Frankel, M., Heinrich, J.P., Hickenbottom, S., Karp, H., La Bresh, K.A., Malarcher, A., Menash, G., Moomaw, C.J., Schwamm, L., & Weiss, P. Paul Cloverdale Prototype Registries Writing Group. (2005). Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke, 36(6), 1232-1240.
26. Riek-Burchardt, M., Henrich-Noack, P., Metz, G.A. & Reymann, K.G. (2004). Detection of chronic sensorimotor impairments in the ladder rung walking task in rats with endothelin-1-induced mild focal ischemia. J Neurosci Methods, 137(2), 227-233.
27. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Makuc, D.M., Marcus, G.M., Marelli, A., Matchar, D.B., Moy, C.S., Mozaffarian, D., Mussolino, M.E., Nichol, G., Paynter, N.P., Soliman, E.Z., Sorlie, P.D., Sotoodehnia, N., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D. & Turner, M.B. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2012). Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 125(1), e2-e220.
28. Rossignol, J., Boyer, C., Thinard, R., Remy, S., Dugast, A.S., Dubayle, D., Dey, N.D., Boeffard, F., Delecrin, J., Heymann, D., Vanhove, B., Anegon, I., Naveilhan, P., Dunbar, G.L. & Lescaudron, L. (2009). Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med, 13(8B), 2547-2558.
29. Rossignol, J., Boyer, C., Lévèque, X., Fink, K.D., Thinard, R., Blanchard, F., Dunbar, G.L. & Lescaudron, L. (2011). Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes. Behav Brain Res, 217(2), 369-378.
30. Sharkey, J. & Butcher, S.P. (1995). Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery. J Neurosci Methods, 60(1-2), 125-131.
31. Soleman, S., Yip, P., Leasure, J.L. & Moon, L. (2010). Sustained sensorimotor impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged rats. Exp Neurol, 222(1), 13-24.
32. Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C. & Sharp, F.R. (1990). A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab, 10(2), 290-293.
33. Wade, D.T. & Hewer, R.L. (1987). Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry, 50(2), 177-182.